Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Bimekizumab quickly improves psoriasis symptoms and skin at the molecular level.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Tofacitinib significantly improved skin and hair conditions without side effects.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Bimekizumab effectively treated a man's chronic beard hair loss.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.